Visium Asset Management’s Quest Diagnostics DGX Stock Holding History

Visium Asset Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-50,000	Closed	-$3.57M	–	385
2016 Q1	$3.57M	Sell	50,000 -10,000	-17%	-$671K	0.06%	321
2015 Q4	$4.27M	Buy	+60,000	New	+$4.03M	0.06%	301
2015 Q3	–	Sell	-200	Closed	-$3K	–	964
2015 Q2	$3K	Buy	+200	New	+$14.8K	﹤0.01%	1110
2015 Q1	–	Sell	-50,000	Closed	-$3.35M	–	1059
2014 Q4	$3.35M	Buy	+50,000	New	+$3.16M	0.05%	336
2014 Q2	–	Sell	-897,600	Closed	-$52M	–	1125
2014 Q1	$52M	Buy	897,600 +896,574	+87,385%	+$48.1M	0.84%	16
2013 Q4	$121K	Buy	+1,026	New	+$60.9K	﹤0.01%	840

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return

Visium Asset Management's DGX Position: Q3 2015 in Review

Visium Asset Management sold out of Quest Diagnostics (DGX) in Q3 2015, closing a stake of 28,872 shares — an estimated $2.09M sold.

Visium Asset Management first reported a position in DGX in Q4 2013 and held it in 7 quarters. The position peaked at $18.4M in Q1 2014. 540 funds tracked by Wall St. Rank hold DGX as of Q3 2015.

Visium Asset Management reported no remaining Quest Diagnostics position as of Q3 2015 after selling out during the quarter.
Visium Asset Management sold 28,872 Quest Diagnostics shares in Q3 2015, an estimated $2.09M.
Visium Asset Management first reported a position in Quest Diagnostics in Q4 2013 and held it in 7 quarters.
Visium Asset Management's Quest Diagnostics position peaked at $18.4M in Q1 2014.
540 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2015.

Based on Visium Asset Management's 13F filing for Q3 2015, filed 16 Nov 2015.